{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:22:14Z","timestamp":1750537334015,"version":"3.37.3"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230618","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:34:40Z","timestamp":1587144880000},"page":"e0230618","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9629-0553","authenticated-orcid":true,"given":"Brigitte","family":"Fuenfgeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-7684","authenticated-orcid":true,"given":"Philipp","family":"M\u00e4chler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee R.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Jane","family":"Rushing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Stolzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Huellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"pone.0230618.ref001","first-page":"143","volume-title":"Molecular Anatomic Imaging: PET\/CT, PET\/MR, and SPECT\/CT","author":"A Buck","year":"2016"},{"key":"pone.0230618.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286418759865","article-title":"Imaging in neuro-oncology","volume":"11","author":"H Nandu","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"pone.0230618.ref003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cpet.2012.09.005","article-title":"FET PET in Neuro-oncology and in Evaluation of Treatment Response","volume":"8","author":"V Dunet","year":"2013","journal-title":"PET Clin"},{"issue":"104","key":"pone.0230618.ref004","article-title":"[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients\u2014A Review","volume":"3","author":"I G\u00f6tz","year":"2013","journal-title":"Front Oncol"},{"issue":"2","key":"pone.0230618.ref005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00381-014-2552-y","article-title":"(18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors","volume":"31","author":"M Misch","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"pone.0230618.ref006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymeth.2017.05.019","article-title":"Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine (FET)","volume":"130","author":"K-J Langen","year":"2017","journal-title":"Methods"},{"issue":"3","key":"pone.0230618.ref007","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/neuonc\/nos300","article-title":"[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma","volume":"15","author":"M Hutterer","year":"2013","journal-title":"Neuro Oncol"},{"issue":"2","key":"pone.0230618.ref008","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40336-017-0222-2","article-title":"Positron emission tomography and magnetic resonance spectroscopy in cerebral gliomas","volume":"5","author":"T Pyka","year":"2017","journal-title":"Clin Transl Imaging"},{"issue":"5","key":"pone.0230618.ref009","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","article-title":"Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies","volume":"15","author":"N Verma","year":"2013","journal-title":"Neuro Oncol"},{"issue":"3","key":"pone.0230618.ref010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.wno.0000177307.21081.81","article-title":"Magnetic Resonance Spectroscopy","volume":"25","author":"SK Gujar","year":"2005","journal-title":"J Neuro-Ophthalmol"},{"issue":"3","key":"pone.0230618.ref011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/neuros\/nyx103","article-title":"Current Clinical Brain Tumor Imaging","volume":"81","author":"JE Villanueva-Meyer","year":"2017","journal-title":"Neurosurgery"},{"issue":"3","key":"pone.0230618.ref012","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nurt.2009.05.002","article-title":"Neuroimaging in neuro-oncology","volume":"6","author":"S. Cha","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"9","key":"pone.0230618.ref013","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"NL Albert","year":"2016","journal-title":"Neuro Oncol"},{"issue":"4","key":"pone.0230618.ref014","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","article-title":"Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET and MRI in Low-Grade Glioma","volume":"48","author":"FW Floeth","year":"2007","journal-title":"J Nucl Med"},{"issue":"3","key":"pone.0230618.ref015","first-page":"374","article-title":"Comparison of O-(2-18F-Fluoroethyl)-l-Tyrosine PET and 3-123I-Iodo-\u03b1-Methyl-l-Tyrosine SPECT in Brain Tumors","volume":"45","author":"D Pauleit","year":"2004","journal-title":"J Nucl Med"},{"issue":"7","key":"pone.0230618.ref016","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2009.05.005","article-title":"Comparison of (18)F-FET and (18)F-FDG PET in brain tumors","volume":"36","author":"D Pauleit","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"8","key":"pone.0230618.ref017","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/neuonc\/nor054","article-title":"Molecular imaging of gliomas with PET: Opportunities and limitations","volume":"13","author":"C la Foug\u00e8re","year":"2011","journal-title":"Neuro Oncol"},{"issue":"12","key":"pone.0230618.ref018","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2967\/jnumed.113.123836","article-title":"Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma","volume":"54","author":"N Galldiks","year":"2013","journal-title":"J Nucl Med"},{"issue":"10","key":"pone.0230618.ref019","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/RLU.0b013e3182291b40","article-title":"Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy","volume":"36","author":"ML Calcagni","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"3","key":"pone.0230618.ref020","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3892\/ol.2016.4189","article-title":"18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report","volume":"11","author":"S Kebir","year":"2016","journal-title":"Oncol Lett"},{"issue":"12","key":"pone.0230618.ref021","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2967\/jnumed.107.046615","article-title":"Differential Uptake of O-(2-18F-Fluoroethyl)-l-Tyrosine, l-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses","volume":"48","author":"D Salber","year":"2007","journal-title":"J Nucl Med"},{"issue":"11","key":"pone.0230618.ref022","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1097\/RLU.0000000000002244","article-title":"Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease\u2014Preliminary Experience From a Retrospective Analysis","volume":"43","author":"M Barbagallo","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"5","key":"pone.0230618.ref023","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.nucmedbio.2011.11.002","article-title":"Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax","volume":"39","author":"IA Burger","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"8","key":"pone.0230618.ref024","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s00330-014-3222-x","article-title":"Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak","volume":"24","author":"E Laffon","year":"2014","journal-title":"Eur Radiol"},{"issue":"11","key":"pone.0230618.ref025","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00259-004-1590-1","article-title":"Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma","volume":"31","author":"G P\u00f6pperl","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0230618.ref026","first-page":"1","article-title":"Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0","author":"I Law","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"pone.0230618.ref027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0009-8981(03)00133-5","article-title":"Reference intervals: an update","volume":"334","author":"PS Horn","year":"2003","journal-title":"Clin Chim Acta"},{"issue":"1","key":"pone.0230618.ref028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J Royal Stat Soc"},{"issue":"6","key":"pone.0230618.ref029","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"DN Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"4","key":"pone.0230618.ref030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/014662168801200410","article-title":"Set Correlation and Contingency Tables","volume":"12","author":"J. Cohen","year":"1988","journal-title":"Appl Psychol Meas"},{"key":"pone.0230618.ref031","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinimag.2018.01.015","article-title":"Value of 18F-FET PET in adult brainstem glioma","volume":"51","author":"AA Albatly","year":"2018","journal-title":"Clin Imaging"},{"key":"pone.0230618.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867325666171123202644","article-title":"Recent Developments of 18F-FET PET in Neuro-oncology","volume":"25","author":"B Muoio","year":"2018","journal-title":"Curr Med Chem"},{"issue":"2","key":"pone.0230618.ref033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2967\/jnumed.111.096859","article-title":"Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis","volume":"53","author":"V Dunet","year":"2012","journal-title":"J Nucl Med"},{"issue":"11","key":"pone.0230618.ref034","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/RLU.0000000000002266","article-title":"Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression","volume":"43","author":"M Unterrainer","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"9","key":"pone.0230618.ref035","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/RLU.0000000000002197","article-title":"FET PET in Primary Central Nervous System Vasculitis","volume":"43","author":"L Burghaus","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"12","key":"pone.0230618.ref036","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1097\/RLU.0000000000001873","article-title":"AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1\/2 Expression of Inflammatory Cells","volume":"42","author":"M Hutterer","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"3","key":"pone.0230618.ref037","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/RLU.0000000000001516","article-title":"Neurosarcoidosis on FET and FDG PET\/CT","volume":"42","author":"M Chan","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"4","key":"pone.0230618.ref038","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00259-004-1705-8","article-title":"O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours","volume":"32","author":"M Weckesser","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"pone.0230618.ref039","first-page":"776","article-title":"18F-FET PET differentiation of ring-enhancing brain lesions","volume":"47","author":"FW Floeth","year":"2006","journal-title":"J Nucl Med"},{"issue":"5","key":"pone.0230618.ref040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2967\/jnumed.107.050005","article-title":"Prognostic Value of 18F-Fluoroethyl-l-Tyrosine PET and MRI in Small Nonspecific Incidental Brain Lesions","volume":"49","author":"FW Floeth","year":"2008","journal-title":"J Nucl Med"},{"issue":"5","key":"pone.0230618.ref041","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","article-title":"O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study","volume":"27","author":"WA Weber","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"pone.0230618.ref042","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas","volume":"128","author":"D Pauleit","year":"2005","journal-title":"Brain"},{"issue":"6","key":"pone.0230618.ref043","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.wneu.2015.07.067","article-title":"Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases","volume":"84","author":"J Gempt","year":"2015","journal-title":"World Neurosurg"},{"issue":"8","key":"pone.0230618.ref044","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00259-010-1457-6","article-title":"Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?","volume":"37","author":"R Pichler","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"pone.0230618.ref045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2967\/jnumed.109.071423","article-title":"Comparison of O-(2-18F-Fluoroethyl)-l-Tyrosine and l-3H-Methionine Uptake in Cerebral Hematomas","volume":"51","author":"D Salber","year":"2010","journal-title":"J Nucl Med"},{"issue":"4","key":"pone.0230618.ref046","doi-asserted-by":"crossref","first-page":"e95830","DOI":"10.1371\/journal.pone.0095830","article-title":"An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas","volume":"9","author":"M Nowosielski","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pone.0230618.ref047","first-page":"455","article-title":"Stereotactic Comparison among Cerebral Blood Volume, Methionine Uptake, and Histopathology in Brain Glioma","volume":"28","author":"N Sadeghi","year":"2007","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"pone.0230618.ref048","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ijrobp.2010.07.002","article-title":"An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases","volume":"81","author":"A-L Grosu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"pone.0230618.ref049","first-page":"1367","article-title":"Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo","volume":"40","author":"P Heiss","year":"1999","journal-title":"J Nucl Med"},{"issue":"3","key":"pone.0230618.ref050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00259-016-3585-0","article-title":"Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma","volume":"44","author":"J Gottler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"pone.0230618.ref051","doi-asserted-by":"crossref","first-page":"e0199379","DOI":"10.1371\/journal.pone.0199379","article-title":"Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas","volume":"13","author":"P Blanc-Durand","year":"2018","journal-title":"PLOS ONE"},{"issue":"1","key":"pone.0230618.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-017-0295-y","article-title":"Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?","volume":"7","author":"M Unterrainer","year":"2017","journal-title":"EJNMMI Research"},{"issue":"2","key":"pone.0230618.ref053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40336-016-0213-8","article-title":"Clinical PET\/MRI in neurooncology: opportunities and challenges from a single-institution perspective","volume":"5","author":"L Marner","year":"2017","journal-title":"Clin Transl Imaging"},{"issue":"5","key":"pone.0230618.ref054","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/14737140.2017.1302799","article-title":"Amino acid PET in neuro-oncology: applications in the clinic","volume":"17","author":"N Galldiks","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"pone.0230618.ref055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejrad.2013.05.028","article-title":"Competitive advantage of PET\/MRI","volume":"83","author":"H Jadvar","year":"2014","journal-title":"Eur J Radiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T06:40:23Z","timestamp":1722753623000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230618"}},"subtitle":[],"editor":[{"given":"Pradeep K.","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230618","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,4,17]]}}}